Sponsor
Remix Therapeutics Inc.
100 Forge Road Suite 400, 02472-2265, United States
About the sponsor
Remix Therapeutics Inc. is active in adenoid cystic carcinoma, with research centered on recurrent or metastatic disease. Its clinical interest in this area reflects a focus on difficult-to-treat cancers arising in the salivary glands and related head and neck tissues.
- Adenoid cystic carcinoma
- Recurrent disease
- Metastatic cancer
The sponsor’s work in this domain aligns with oncology programs aimed at advancing treatment options for rare and aggressive solid tumours.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.